Kazia Therapeutics KZIA
NASDAQ KZIA
$8.21 +0.03 (+0.37%)
As of: Oct 22, 2026 · 11:52 AM EDT

Kazia Therapeutics (KZIA) Share-based Compensation (IS) (2009 - 2013)

Updated

Kazia Therapeutics (KZIA) reported Share-based Compensation (IS) of -$372,547 for the quarter ended Dec 31, 2013.

Analysis

Kazia Therapeutics (KZIA) Share-based Compensation (IS) (2009 - 2013) Analysis & Trends

For the year ended Dec 31, 2013, Kazia Therapeutics posted Share-based Compensation (IS) of -$389,475.

  • By year, Share-based Compensation (IS) came in at -$513,610 in the year ended Dec 31, 2012, -$502,831 in the year ended Dec 31, 2011, $642,291 in the year ended Jun 30, 2010 and $840,778 in the year ended Dec 31, 2009.
  • The figure for the quarter ended Dec 31, 2013 ranks as the lowest quarterly Share-based Compensation (IS) since the quarter ended Dec 31, 2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,170.86 Bn 1,139.45 Bn 19.71 Bn -
2 Johnson & Johnson 639.81 Bn 558.34 Bn 17.26 Bn -
3 AbbVie 501.68 Bn 474.79 Bn 12.70 Bn -
4 Merck 374.79 Bn 329.16 Bn 12.21 Bn -
5 Novartis Ag 302.69 Bn 266.68 Bn 11.24 Bn -
6 Astrazeneca 268.27 Bn 241.96 Bn 12.86 Bn -
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn -
8 Gilead Sciences 193.38 Bn 167.58 Bn 6.22 Bn -
9 Pfizer 172.45 Bn 119.10 Bn 10.94 Bn -
10 Kazia Therapeutics 605,189.81 -51.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -372,546.63
Aug 30, 2013 -370,415.50
Dec 31, 2012 -515,189.70
Jun 30, 2010 -643,578.42
Dec 31, 2009 -362,000.00
API Access

Kazia Therapeutics Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=KZIA&period=max&api_key=YOUR_API_KEY